TQB3107

· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TQB3107, covering 2024-07-03 to 2024-07-03. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of TQB3107 Tablets in Patients With Malignant Tumors [Phase 1]